McKesson To Acquire Precision Medicine Group For $2.25 Bln
(RTTNews) - Tuesday, McKesson Corp. (MCK) announced an agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services, for approximately $2.25 billion.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.